Crossmark

Quality of life and effectiveness of vutrisiran as treatment for hereditary transthyretin amyloidosis

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.12.010

Published Print: 2026-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Corazón Villanueva, Javier

García Sacristán, Ana Andrea
License Information

Text and Data Mining valid from 2026-09-01

Text and Data Mining valid from 2026-09-01

Version of Record valid from 2026-01-08
More Information

This article is maintained by: Elsevier

Article Title: Quality of life and effectiveness of vutrisiran as treatment for hereditary transthyretin amyloidosis

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.12.010

Content Type: article

Copyright: © 2026 Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier España, S.L.U.